NUMBER NUMBER NUMBER patients anal canal carcinoma treated NUMBER radiotherapy rt NUMBER chemoradiotherapy crt NUMBER respectively NUMBER patients onset therapy rt given total dose NUMBER gy weeks crt additional simultaneous NUMBER days NUMBER NUMBER NUMBER NUMBER mitomycin c NUMBER days NUMBER NUMBER administered NUMBER respectively NUMBER patients uicc stage ii iiib disease predominantly g2 g3 squamous cell carcinomas local control years NUMBER rt group vs NUMBER crt group survival rate NUMBER NUMBER respectively differences significant compared significantly higher survival rate acute late damage slightly lower rt treatment group NUMBER NUMBER compared crt group NUMBER NUMBER treatment groups patient needing permanent colostomy radiation induced proctitis conclusion rt crt primary form treatment patients canal carcinoma abdominoperineal resection performed case local recurrence tumor persistence final decision indications rt crt results prospective randomized trial colostomy free NUMBER fluorouracil year g1 g3 tumors mg m2 mg m2